Image Guided Radiotherapy Market Size & Share 2024 - 2032

Image Guided Radiotherapy Market Size

Image Guided Radiotherapy Market size was valued at USD 1.9 billion in 2023 and is anticipated to witness growth at a CAGR of 7.3% between 2024 and 2032. The image-guided radiotherapy market is experiencing growth driven by the increasing incidence of cancer, a surging preference for personalized treatment planning, and a rise in the adoption of non-invasive cancer treatment.

The global incidence of cancer continues to rise, driven by factors such as population growth, aging demographics, lifestyle changes, and environmental factors. Cancer remains a significant public health concern worldwide, with millions of new cases diagnosed each year. For instance, according to the American Cancer Society, in 2022, approximately 20 million new cancer cases were diagnosed, resulting in 9.7 million deaths worldwide. With the increasing number of cancer patients, there is a growing demand for advanced treatment modalities like image-guided radiotherapy, which can effectively target and treat tumors while minimizing damage to surrounding healthy tissues.
 

Furthermore, non-invasive cancer treatments like image-guided radiotherapy (IGRT) are associated with fewer treatment-related side effects compared to invasive surgical procedures or systemic therapies such as chemotherapy. By delivering highly targeted radiation doses to cancerous tissues while sparing nearby healthy organs and tissues, IGRT minimizes the risk of radiation-induced toxicity and long-term complications. This not only improves patient tolerance to treatment but also enhances their overall treatment experience, leading to greater patient satisfaction and compliance.
 

Image-guided radiotherapy is a highly advanced form of radiation therapy that utilizes real-time imaging techniques to precisely target and deliver therapeutic radiation to tumors while minimizing exposure to surrounding healthy tissues. It integrates various imaging modalities such as computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET) to visualize tumors and adjacent anatomy with high accuracy during both treatment planning and delivery.

Image Guided Radiotherapy Market Trends

• Technological innovations in radiotherapy devices have led to the development of more precise and accurate delivery systems for radiation therapy.
   
• Modern radiotherapy devices incorporate sophisticated treatment planning software and algorithms that enable clinicians to optimize radiation dose distributions and treatment plans based on patient-specific factors and tumor characteristics.
   
• These tools facilitate personalized treatment approaches tailored to individual patient needs, leading to improved treatment outcomes and patient satisfaction."
   
• The accelerated development of vaccines and therapies to combat infectious diseases further contributes to this demand.
   
• Moreover, radiotherapy devices now integrate advanced image guidance systems, such as onboard CBCT or MRI, directly into treatment delivery platforms. For instance, Elekta Unity, an MR-Linac device by Elekta, combines the imaging capabilities of MRI systems with the therapeutic capabilities of a linear accelerator (LINAC) in a single integrated system.
   
• This innovative approach allows for real-time visualization of soft tissues and tumors during radiation therapy delivery, providing unprecedented image guidance and accuracy. By enabling continuous visualization of the tumor and surrounding anatomy, Elekta Unity enhances treatment precision and enables seamless implementation of adaptive radiotherapy strategies.
   

Image Guided Radiotherapy Market Analysis

Based on product type, the market is segmented into radiotherapy/LINAC (linear accelerators) devices and imaging devices. The radiotherapy/LINAC (linear accelerators) segment held a significant market share of 53.6% in 2023.
 

• LINACs are highly versatile radiation therapy devices capable of delivering a wide range of treatment modalities, including intensity-modulated radiation therapy (IMRT), stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), and volumetric modulated arc therapy (VMAT). This versatility allows LINACs to address diverse clinical needs and treat a variety of tumor types with precision and accuracy.
   
• Additionally, LINACs are designed for high treatment efficiency, offering fast treatment delivery times and streamlined workflow capabilities. Advanced treatment planning software and automated beam delivery systems optimize treatment processes, minimizing treatment times and maximizing patient throughput.
   
• This high treatment efficiency enables healthcare providers to deliver timely and cost-effective radiotherapy treatments while maintaining high standards of care, thereby fueling the growth of this segment.
   

Based on application, the image guided radiotherapy market is classified into breast cancer, lung cancer, brain tumor, prostate cancer, gastrointestinal cancer, gynecological cancer, and other applications. The breast cancer segment accounted for the highest market share and was valued at USD 483.3 million in 2023.
 

• Breast cancer is one of the most commonly diagnosed cancers globally, with a high incidence rate among women. For instance, according to the World Health Organization, in 2022, there were 2.3 million women diagnosed with breast cancer and 670,000 deaths globally. The growing prevalence of breast cancer drives the demand for effective and targeted radiotherapy treatments, making it a significant application area for IGRT technologies.
   
• Moreover, the complex anatomy of the breast and surrounding tissues requires precise targeting during radiotherapy to ensure optimal tumor coverage while sparing healthy surrounding structures.
   
• IGRT techniques, such as cone-beam CT scanner and image-guided adaptive radiotherapy, provide real-time imaging guidance to accurately localize the tumor and adjust treatment plans as needed, thereby improving treatment outcomes and minimizing side effects.
   
• Further, many women with early-stage breast cancer undergo breast conservation therapy, which involves lumpectomy followed by adjuvant radiotherapy to the breast.
   
• IGRT techniques enable clinicians to precisely target the tumor bed and surrounding tissues while minimizing radiation exposure to the unaffected breast tissue and critical organs, facilitating successful breast conservation therapy with excellent cosmetic outcomes. Such aforementioned factors drive the growth of this segment.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on end-use, the image guided radiotherapy market is categorized into hospitals, radiotherapy centers, and other end-users. The hospitals segment is projected to reach USD 1.7 billion by 2032.
 

• Hospitals serve as central hubs for cancer diagnosis, treatment, and management, offering comprehensive oncology services to patients. With the increasing prevalence of cancer and the growing demand for advanced radiotherapy treatments, hospitals play a pivotal role in delivering Image-Guided Radiotherapy (IGRT) services to a large patient population.
   
• Many hospitals are equipped with state-of-the-art radiotherapy centers featuring advanced IGRT technologies, including linear accelerators (LINACs) with onboard imaging capabilities such as cone-beam computed tomography (CBCT) or integrated magnetic resonance imaging (MRI).
   
• These facilities enable hospitals to provide cutting-edge IGRT treatments to patients with various types of cancer, including breast, prostate, lung, and head and neck cancers.
   

North America image guided radiotherapy market size in 2023 was valued at USD 802.3 million and is predicted to grow at a CAGR of 6.9% over the analysis timeframe.
 

• North America dominates the image-guided radiotherapy market due to its strong medical devices industry and stringent regulatory environment.
   
• The region also benefits from significant investment in research and development within the cancer treatment sectors, fueling the demand for advanced radiotherapy devices.
   
• Furthermore, the region leads in the adoption of technologies like image-guided radiotherapy, enhancing treatment efficiency and accuracy, thereby propelling the growth of this market.
   

U.S. image guided radiotherapy market is anticipated to grow at a CAGR of 6.8% to reach USD 1.3 billion by the end of the forecast timeframe.
 

• The U.S. has a high incidence of cancer, with millions of new cancer cases diagnosed each year across various cancer types.
   
• For instance, according to the American Cancer Society, in 2022, there were an estimated 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the U.S.
   
• The prevalence of cancer drives the need for advanced radiotherapy modalities such as IGRT, which offer precise and targeted treatment delivery while minimizing damage to surrounding healthy tissues.
   

Germany image guided radiotherapy market is projected to grow remarkably in the coming years.
 

• The German government provides robust support for cancer care and treatment through its healthcare system.
   
• Reimbursement policies ensure that patients have access to advanced radiotherapy treatments, including IGRT, without facing significant financial burdens.
   
• German healthcare professionals, including radiation oncologists, medical physicists, and radiation therapists, are recognized for their clinical expertise and commitment to delivering high-quality patient care.
   
• Their proficiency in utilizing IGRT technologies ensures optimal treatment outcomes for cancer patients, contributing to the growth of the market in the region.
   

Japan is experiencing high market growth in the image guided radiotherapy market.
 

• Japan is known for its prowess in technological innovation, including the development of cutting-edge medical devices and imaging technologies.
   
• Many Japanese companies are leaders in the field of radiation oncology and have developed advanced IGRT systems known for their precision, reliability, and efficiency.
   
• Additionally, Japan has one of the world's most rapidly aging populations, with a significant proportion of elderly individuals susceptible to age-related diseases, including cancer.
   
• The increasing prevalence of cancer among older adults drives the demand for radiotherapy treatments, including IGRT, to effectively manage the disease and improve patient outcomes, contributing to the expansion of the market.
   

Image Guided Radiotherapy Market Share

The image guided radiotherapy industry is characterized by the presence of several established and emerging players that offer a variety of products and services across the globe. The market players compete based on factors such as product quality, innovation, customer service, and pricing strategies.
 

Image Guided Radiotherapy Market Companies

Prominent players operating in the image guided radiotherapy industry include:

• Accuray Incorporated
• C-RAD
• Elekta
• GE Healthcare
• Hitachi, Ltd.
• Philips
• Siemens Healthineers
• Varian Medical Systems, Inc.
• ViewRay, Inc.
• Vision RT Ltd.
   

Image Guided Radiotherapy Industry News:

• In October 2023, Hitachi, Ltd. announced the delivery of a proton therapy system to the National Cancer Centre Singapore, with the first patient treatment completed on 11 August 2023. This marks Hitachi's first proton therapy system to commence treatment in Southeast Asia. This strategic launch may help the company improve its business revenue and increase its customer base.
   
• In October 2020, Elekta announced the launch of its new Elekta Harmony linear accelerator (linac), a cancer treatment system. This strategic product launch helped the company enhance its offerings and generate revenue.
   

The image guided radiotherapy market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 - 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Radiotherapy/LINAC (Linear Accelerators) devices
• Imaging devices
  • CT scan
  • MRI
  • PET scan
  • Other imaging devices

Market, By Application

• Breast cancer
• Lung cancer
• Brain tumor
• Prostate cancer
• Gastrointestinal cancer
• Gynecological cancer
• Other applications

Market, By End-use

• Hospitals
• Radiotherapy centers
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa